curacle co., ltd. Logo

curacle co., ltd.

Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.

365270 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서초구 효령로 23-1, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Curacle Co., Ltd. is a biopharmaceutical company established in 2016, specializing in the research and development of innovative drugs for intractable diseases. The company focuses on conditions arising from vascular damage and the aging process, with a particular emphasis on treatments for diseases like diabetes and stroke. Leveraging its unique research and platform technologies, Curacle develops a pipeline of new drug candidates to address significant unmet medical needs. The company aims to create treatments with high commercial potential and marketability.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for curacle co., ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.1 KB
2025-09-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.3 KB
2025-09-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-09-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 101.4 KB
2025-09-09 00:00
Share Issue/Capital Change
증권발행실적보고서
Korean 113.1 KB
2025-09-09 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (주주배정후 실권주 일반공모)
Korean 8.1 KB
2025-09-09 00:00
Share Issue/Capital Change
[기재정정]증권발행실적보고서
Korean 121.2 KB
2025-09-08 00:00
Share Issue/Capital Change
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)
Korean 10.3 KB
2025-09-03 00:00
Share Issue/Capital Change
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)
Korean 9.7 KB
2025-08-28 00:00
Share Issue/Capital Change
유상증자최종발행가액확정
Korean 11.4 KB
2025-08-28 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 41.6 KB
2025-08-28 00:00
Registration Form
[발행조건확정]증권신고서(지분증권)
Korean 260.5 KB
2025-08-28 00:00
Prospectus
[기재정정]투자설명서
Korean 2.2 MB

Automate Your Workflow. Get a real-time feed of all curacle co., ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for curacle co., ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Orion Oyj Logo
Develops and manufactures human/vet pharma, APIs, and generics for global markets.
Finland ORNAV
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea 475830
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom OCTHF
PAION AG Logo
Developed drugs for hospital-based sedation, anesthesia, and critical care.
Germany PA8
Pangen Biotech Inc. Logo
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea 222110
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany PTP
PeopleBio, Inc. Logo
Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.
South Korea 304840

Talk to a Data Expert

Have a question? We'll get back to you promptly.